Group One Trading’s Amicus Therapeutics FOLD Stock Holding History

Group One Trading’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$224K	Sell	15,500 -7,200	-32%	-$103K	﹤0.01%	4019
2025 Q4	$323K	Buy	22,700 +6,300	+38%	+$61.9K	﹤0.01%	3940
2025 Q3	$129K	Buy	16,400 +2,100	+15%	+$14.9K	﹤0.01%	5104
2025 Q2	$81.9K	Buy	14,300 +4,600	+47%	+$29.7K	﹤0.01%	5149
2025 Q1	$79.2K	Sell	9,700 -16,700	-63%	-$155K	﹤0.01%	4781
2024 Q4	$249K	Sell	26,400 -48,900	-65%	-$508K	﹤0.01%	3768
2024 Q3	$804K	Buy	75,300 +56,400	+298%	+$614K	﹤0.01%	2482
2024 Q2	$187K	Sell	18,900 -400	-2%	-$4.11K	﹤0.01%	3448
2024 Q1	$227K	Sell	19,300 -80,900	-81%	-$1.03M	﹤0.01%	3466
2023 Q4	$1.42M	Buy	100,200 +65,400	+188%	+$743K	﹤0.01%	2145
2023 Q3	$423K	Buy	34,800 +14,700	+73%	+$190K	﹤0.01%	3069
2023 Q2	$252K	Buy	20,100 +4,900	+32%	+$58.1K	﹤0.01%	3694
2023 Q1	$169K	Sell	15,200 -12,400	-45%	-$153K	﹤0.01%	3822
2022 Q4	$337K	Sell	27,600 -23,400	-46%	-$263K	﹤0.01%	3397
2022 Q3	$532K	Sell	51,000 -28,500	-36%	-$318K	﹤0.01%	3172
2022 Q2	$854K	Buy	79,500 +27,500	+53%	+$226K	﹤0.01%	2916
2022 Q1	$492K	Buy	52,000 +13,000	+33%	+$122K	﹤0.01%	3834
2021 Q4	$450K	Sell	39,000 -61,500	-61%	-$685K	﹤0.01%	4253
2021 Q3	$960K	Sell	100,500 -8,600	-8%	-$88K	﹤0.01%	3458
2021 Q2	$1.05M	Sell	109,100 -37,500	-26%	-$366K	﹤0.01%	3357
2021 Q1	$1.45M	Buy	146,600 +22,900	+19%	+$354K	﹤0.01%	2802
2020 Q4	$2.86M	Buy	123,700 +57,900	+88%	+$1.18M	﹤0.01%	1741
2020 Q3	$929K	Sell	65,800 -573,600	-90%	-$8.36M	﹤0.01%	2262
2020 Q2	$9.64M	Buy	639,400 +565,300	+763%	+$6.89M	0.04%	455
2020 Q1	$685K	Sell	74,100 -51,900	-41%	-$493K	0.01%	1818
2019 Q4	$1.23M	Buy	126,000 +22,000	+21%	+$201K	0.01%	1710
2019 Q3	$834K	Sell	104,000 -29,000	-22%	-$315K	0.01%	1888
2019 Q2	$1.66M	Sell	133,000 -18,900	-12%	-$240K	0.02%	1224
2019 Q1	$2.07M	Buy	151,900 +22,200	+17%	+$271K	0.02%	910
2018 Q4	$1.24M	Sell	129,700 -85,900	-40%	-$944K	0.01%	1348
2018 Q3	$2.61M	Sell	215,600 -154,200	-42%	-$2.16M	0.02%	970
2018 Q2	$5.78M	Sell	369,800 -662,100	-64%	-$10M	0.05%	472
2018 Q1	$15.5M	Buy	1,031,900 +699,500	+210%	+$10.6M	0.16%	120
2017 Q4	$4.78M	Sell	332,400 -94,200	-22%	-$1.29M	0.03%	660
2017 Q3	$6.43M	Buy	426,600 +199,400	+88%	+$2.64M	0.06%	412
2017 Q2	$2.29M	Sell	227,200 -30,300	-12%	-$244K	0.02%	876
2017 Q1	$1.84M	Sell	257,500 -99,900	-28%	-$632K	0.02%	919
2016 Q4	$1.78M	Buy	357,400 +56,100	+19%	+$388K	0.02%	980
2016 Q3	$2.23M	Buy	301,300 +49,100	+19%	+$332K	0.02%	795
2016 Q2	$1.38M	Sell	252,200 -112,900	-31%	-$790K	0.02%	1032
2016 Q1	$3.08M	Buy	365,100 +278,700	+323%	+$1.97M	0.04%	555
2015 Q4	$838K	Sell	86,400 -201,100	-70%	-$1.81M	0.01%	1425
2015 Q3	$4.02M	Sell	287,500 -126,900	-31%	-$1.99M	0.06%	422
2015 Q2	$5.86M	Buy	414,400 +225,700	+120%	+$2.71M	0.08%	267
2015 Q1	$2.05M	Buy	188,700 +33,300	+21%	+$294K	0.03%	623
2014 Q4	$1.29M	Sell	155,400 -130,500	-46%	-$896K	0.02%	907
2014 Q3	$1.7M	Buy	285,900 +207,100	+263%	+$1.09M	0.03%	782
2014 Q2	$263K	Buy	78,800 +51,600	+190%	+$121K	﹤0.01%	2162
2014 Q1	$56K	Sell	27,200 -12,000	-31%	-$30K	﹤0.01%	3548
2013 Q4	$92K	Sell	39,200 -23,600	-38%	-$51.8K	﹤0.01%	3113
2013 Q3	$146K	Buy	62,800 +20,100	+47%	+$50.4K	﹤0.01%	2671
2013 Q2	$99K	Buy	+42,700	New	+$131K	﹤0.01%	2824

Other funds holding FOLD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Group One Trading's FOLD Position: Q1 2026 in Review

Group One Trading reduced its Amicus Therapeutics (FOLD) stake by 42% in Q1 2026, selling an estimated $80.4K and leaving 7,861 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #4614.

Group One Trading first reported a position in FOLD in Q2 2013 and has held it in 37 quarters since. The position peaked at $4.24M in Q3 2017. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

Group One Trading held 7,861 shares of Amicus Therapeutics worth $114K as of Q1 2026.
Group One Trading sold 5,608 Amicus Therapeutics shares in Q1 2026, an estimated $80.4K.
Amicus Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4614 holding.
Group One Trading first reported a position in Amicus Therapeutics in Q2 2013 and has held it in 37 quarters since.
Group One Trading's Amicus Therapeutics position peaked at $4.24M in Q3 2017.
298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.